Opportunities in the Indian BioPharma Industry

An Expert's View about Medical, Health and Cosmetics Products in Malaysia

Posted on: 27 Nov 2011

Given Malaysia’s traditional focus on agriculture, a large percentage of agricultural biotechnology companies are in adding value to food and crops. The healthcare biotechnology development policy is to contribute towards the advancement of healthcare by exploiting Malaysia’s biodiversity for new drug candidates and providing cost effective outsourcing services for biodrug development.

Sector briefing Life Science Opportunities in Malaysia Why Malaysia? Malaysia is one of the Asian countries with plans to become the region?s biotech hub. It will leverage on the strength of the country?s diverse natural resources. The key strengths of Malaysia include its infrastructure, its existing history and advances in medical devices and diagnostics manufacturing, well regulated pharmaceutical industry, availability of GMP certified manufacturing facilities. Given Malaysia?s traditional focus on agriculture, a large percentage of agricultural biotechnology companies are in adding value to Find general information on Malaysian market food and crops. The healthcare biotechnology conditions on UKTI?s website. The Doing development policy is to contribute towards the Business Guide for Malaysia gives an overview advancement of healthcare by exploiting of Malaysia?s economy, business culture, Malaysia?s biodiversity for new drug candidates potential opportunities and an introduction to and providing cost effective outsourcing other relevant issues. services for biodrug development. ?Malaysia will capitalise on the th Under the 10 Malaysia Plan (2010-2015), a country?s biodiversity for number of initiatives have been taken to commercialising the discovery of promote regional development and accelerate health related natural products and growth in designated geographic areas. Five growth corridors were identified. The corridors bio-generic drugs? are established to develop certain subsectors of biotechnology. UK Trade & Investment Sector briefing: Life Science opportunities in Malaysia Malaysia is keen on joint research projects. The Opportunities government?s focus in developing the biotech sector will result in improved investment Malaysia has a wealth of traditional knowledge opportunities which will be favourable for in herbal plant and medical plants. Currently businesses and cost effective R & D there are ongoing efforts to discover novel and propositions. Malaysia has an abundance of bioactive compounds from natural resources. natural rainforest. There is an increase in To streamline biotechnology research and strategic alliances to further accelerate the coordinate biotech research in the various research output. The screening, analysis and research organizations to improve cooperation processing of the native flora for either and reduce duplication, centres of excellence medicinal or therapeutic properties has been around Institutions of Higher Learning have successful in some of the local plants. been set up to attract the set-up of other companies in related areas of expertise. Regional Collaborations Opportunities for UK life sciences companies in M Malaysia also has increased trade and alaysia include: investment collaboration ties with China and therefore will benefit from this rising Clinical Trials and Contract Research importance. Malaysia is one of the six Association of South East Asian Nations Malaysia has a multi-ethnic composition; (ASEAN) nations that will have their Most representing a diverse pool in the areas of Favoured Nations (MRN) rates on Chinese disease and illness that make it ideal for trials goods reduced to 0% by 2010. In tandem, the in preclinical and Phase 1 clinical trials There is same rules apply to China which will enable potential for conducting trials for herbal Malaysian goods to be duty-free to China. medicine, tropical and infectious diseases and stem cell therapy. The Ministry of Health announced that at least 70% of the equity in services sector will be Contract Manufacturing of Medical Devices opened to foreign participation under ASEAN Free Trade Agreement. Liberalisation of the Medical device is a sector that has grown due healthcare sector will allow foreign corporation to the strength in clean technology developed to open hospitals as well as foreign doctors and in Malaysia largely through the semiconductor insurance companies operate in Malaysia. manufacturing industry, which is strong there. This provides both a trained workforce and infrastructure suited to medical devices Foreign life science companies in Malaysia development. A well educated, English speaking population, availability of the Foreign companies with device manufacturing supporting industries makes Malaysia an ideal facilities include B Braun, Ansell, St Jude and location for the manufacture of medical Johnson & Johnson. Others life science related devices. companies include GSK, Avesthagen Ltd (India), Novotech (Australia), Sonafi-Pasteur, Pharmaceuticals Stempeutic Research, Quintiles (US). Recent announcements include Biocon (India), Biogenerics, vaccines are areas of interest as Metabolic Explorer (France), Glyco local pharmaceuticals manufacturers are Biotechnologies (US) conducting ongoing research in bio generics. There is a growing demand of HALAL certified If you have any questions on the opportunities vaccines in Organisation of Islamic Council above, contact the UKTI Malaysia contacts Countries. named in this report. Business opportunities aimed specifically at UK companies are added Multinationals control about 70% of the daily to UKTI?s website. These leads are pharmaceutical market in terms of innovative sourced by our staff overseas in British and specialised products. The local industry Embassies, High Commissions and Consulates, remains focused on the production of generics across all sectors and in over 100 markets. and lower-tech medicines. There is now an expanding generics market due to rising costs. You can be alerted to opportunities in Malaysia on a regular basis by registering on the UKTI R & D UK Trade & Investment Sector briefing: Life Science opportunities in Malaysia website. More on UKTI?s business opportunities UKTI contacts service Angie Yen Senior Manager for Trade & Investment Major events and activities British High Commission Tel: (00603) 2170 2268 Find full details of all Healthcare related Email: angie.yen@fco.gov.uk events on the UKTI website. New export www.ukti.gov.uk events are added daily to the site and you can register to be alerted to them on a daily, weekly or monthly basis Next steps - How UKTI can help UKTI?s Tradeshow Access Programme (TAP) provides grant support for eligible Small & British companies wishing to develop their Medium Sized Enterprises (SME's) to attend business in the Malaysian market are advised trade shows overseas. Find out more about to undertake as much market research and UKTI support for attendance at overseas planning as possible in the UK. UKTI?s team in events Malaysia, with its wide local knowledge and experience, can provide a range of services to Other LifeScience/Healthcare Related British-based companies wishing to grow their Exhibitions in Malaysia business in the Malaysian market. APHM International Healthcare This can include: Conference and Exhibition 2011 ? Provision of market information Date : 6 ? 8 July 2011 ? Validated lists of agents/distributors Venue : Kuala Lumpur Convention ? Key market players or potential http://www.aphmconferences.org customers in the Malaysian market ? Establishment of interest of such Asia + Medica 2011 contacts in working with you The Asia International Medical Supplier, ? Arranging appointments Equipment and Technology Exhibition & ? Organise seminars or other events for Conference you to meet contacts and promote your Date : 5 -6 Oct 2011 company in the Malaysian market Venue : Putra World Trade Centre http://asiamedical.org/factsheet.asp This work is available via our Overseas Market Introduction Service (OMIS) a chargeable Bio Malaysia 2011 service which assists British-based companies Dates: 21-24 Nov 2011 wishing to enter or expand their business in www.biomalaysia.com.my overseas markets. www.protempgroup.com To find out more about commissioning this work, or accessing other UKTI services and specialist advice, please visit the UKTI website to find contact details for your local UKTI office. Whereas every effort has been made to ensure that the information given in this document is accurate, neither UK Trade & Investment nor its parent Departments (the Department for Business, Innovation & Skills, and the Foreign & Commonwealth Office), accept liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, firm, company or other organisation mentioned. Published 2011 by UK Trade & Investment. ©Crown Copyright 2011 You may reuse this information (not including logos, images and case studies) free of charge in any format or medium, under the terms of the Open Government Licence. To view this licence, visit www.nationalarchives.gov.uk/doc/open-government- licence/ or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gsi.gov.uk. This publication is also available from our website at www.ukti.gov.uk or for more information please telephone +44 (0)20 7215 8000. UK Trade & Investment Sector briefing: Life Science opportunities in Malaysia
Posted: 27 November 2011

See more from Medical, Health and Cosmetics Products in Malaysia

Expert Views    
Healthcare Opportunities in Malaysia   By UK Trade & Investment
Opportunities in the Indian BioPharma Industry   By UK Trade & Investment
Healthcare Opportunities   By UK Trade & Investment
Healthcare opportunities   By UK Trade & Investment